Agilent Closes $240M Acquisition of Digital Pathology Software Maker Proscia
The deal adds a vendor-agnostic, FDA-cleared software platform to Agilent's pathology portfolio and extends its reach in companion diagnostics and drug discovery.
Latest Articles
Editor's Top Picks
Could a Different Kind of Blood Test Improve Ovarian Cancer Screening?
Toumy Guettouche, PhD, chief scientific officer at Mercy BioAnalytics and a study co-author, discusses how a blood test measuring proteins on extracellular vesicles detected signs of early-stage ovarian cancer before diagnosis—and what researchers still need to establish before the approach could be used for routine screening.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Nova Biomedical Corrects Glucose Meters Over Risk of Misassigned Patient Results
Screen retention errors can misassign patient glucose results in electronic records, leading to one reported injury and a planned software update.
Equipment & Supply Spotlight
DNA/RNA Extraction Kit Designed to Simplify Molecular Testing Receives CE-IVD Mark
The kit allows laboratories to extract DNA and RNA from a range of clinical specimens using a single method.
News, Know-How & Standards
Disease Detection & Understanding
FDA Clears Cyperus Sperm Separation Device for Fertility Labs
Contrario Medical's single-use device uses a two-membrane design to prepare motile sperm from semen samples.
